266 related articles for article (PubMed ID: 26322275)
21. In vitro activity of seven azole compounds against some clinical isolates of non-dermatophytic filamentous fungi and some dermatophytes.
Oyeka CA; Gugnani HC
Mycopathologia; 1990 Jun; 110(3):157-61. PubMed ID: 2388682
[TBL] [Abstract][Full Text] [Related]
22. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
[TBL] [Abstract][Full Text] [Related]
23. In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole.
Santos DA; Hamdan JS
Mycoses; 2007 Jul; 50(4):286-9. PubMed ID: 17576321
[TBL] [Abstract][Full Text] [Related]
24. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic inhibition of Trichophyton rubrum: in vitro activity and the role of oxidative and nitrosative bursts in fungal death.
Baltazar Lde M; Soares BM; Carneiro HC; Avila TV; Gouveia LF; Souza DG; Ferreira MV; Pinotti M; Santos Dde A; Cisalpino PS
J Antimicrob Chemother; 2013 Feb; 68(2):354-61. PubMed ID: 23134678
[TBL] [Abstract][Full Text] [Related]
26. Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.
Hryncewicz-Gwóźdź A; Kalinowska K; Plomer-Niezgoda E; Bielecki J; Jagielski T
Mycopathologia; 2013 Aug; 176(1-2):49-55. PubMed ID: 23595653
[TBL] [Abstract][Full Text] [Related]
27. Morphological evidences for onion-induced growth inhibition of Trichophyton rubrum and Trichophyton mentagrophytes.
Ghahfarokhi MS; Goodarzi M; Abyaneh MR; Al-Tiraihi T; Seyedipour G
Fitoterapia; 2004 Dec; 75(7-8):645-55. PubMed ID: 15567239
[TBL] [Abstract][Full Text] [Related]
28. Intravenous Iron Sucrose Therapy in Iron Deficiency Anemia in Antenatal and Postnatal Patients.
Mathur M; Shrestha S
JNMA J Nepal Med Assoc; 2015; 53(198):108-12. PubMed ID: 26994030
[TBL] [Abstract][Full Text] [Related]
29. Antifungal activity of violacein purified from a novel strain of Chromobacterium sp. NIIST (MTCC 5522).
Sasidharan A; Sasidharan NK; Amma DB; Vasu RK; Nataraja AV; Bhaskaran K
J Microbiol; 2015 Oct; 53(10):694-701. PubMed ID: 26428920
[TBL] [Abstract][Full Text] [Related]
30. Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum.
Khan MS; Ahmad I
Appl Microbiol Biotechnol; 2011 May; 90(3):1083-94. PubMed ID: 21336686
[TBL] [Abstract][Full Text] [Related]
31. Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment.
de Assis Santos D; de Carvalho Araújo RA; Kohler LM; Machado-Pinto J; Hamdan JS; Cisalpino PS
Int J Antimicrob Agents; 2007 May; 29(5):563-9. PubMed ID: 17331707
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
Denardi LB; Mario DA; Loreto ÉS; Santurio JM; Alves SH
Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
[TBL] [Abstract][Full Text] [Related]
33. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.
Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S
Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activities of the combination of tacrolimus and itraconazole against Trichophyton mentagrophytes.
Ozawa H; Okabayashi K; Kano R; Watanabe S; Hasegawa A
J Vet Med Sci; 2005 Jun; 67(6):629-30. PubMed ID: 15997195
[TBL] [Abstract][Full Text] [Related]
35. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes.
Santos DA; Hamdan JS
Med Mycol; 2006 Jun; 44(4):357-62. PubMed ID: 16772230
[TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
Fernández-Torres B; Vázquez-Veiga H; Llovo X; Pereiro M; Guarro J
Chemotherapy; 2000; 46(6):390-4. PubMed ID: 11053904
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo antidermatophytic activity of saperconazole, a new fluorinated triazole.
Fu KP; Isaacson DM; Lococo J; Foleno B; Hilliard J
Drugs Exp Clin Res; 1992; 18(11-12):443-6. PubMed ID: 1308468
[TBL] [Abstract][Full Text] [Related]
38. In vitro antifungal activity and mechanism of essential oil from fennel (Foeniculum vulgare L.) on dermatophyte species.
Zeng H; Chen X; Liang J
J Med Microbiol; 2015 Jan; 64(Pt 1):93-103. PubMed ID: 25351709
[TBL] [Abstract][Full Text] [Related]
39. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Bhatia VK; Sharma PC
Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
[TBL] [Abstract][Full Text] [Related]
40. Asarones from Acorus calamus in combination with azoles and amphotericin B: a novel synergistic combination to compete against human pathogenic Candida species in vitro.
Kumar SN; Aravind SR; Sreelekha TT; Jacob J; Kumar BS
Appl Biochem Biotechnol; 2015 Apr; 175(8):3683-95. PubMed ID: 25686561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
